Clinical Trial Update: Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of PEG-400 with Systane Artificial Tears for improving quality of vision in individuals with myopia; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Polyethylene Glycol 400 (polyethylene glycol 400)
• Systane Artificial Tears (polyethylene glycol-based artificial tears)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Myopia | Phase 4 | Status: COMPLETED